We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
Cap. Flow
+$208M
Cap. Flow %
11.48%
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$9.12M
2
V icon
Visa
V
+$8.75M
3
MSI icon
Motorola Solutions
MSI
+$7.37M
4
EW icon
Edwards Lifesciences
EW
+$7.3M
5
CTXS
Citrix Systems Inc
CTXS
+$4.48M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.1M
2
BHC icon
Bausch Health
BHC
+$5.94M
3
DE icon
Deere & Co
DE
+$5.72M
4
STZ icon
Constellation Brands
STZ
+$4.59M
5
QCOM icon
Qualcomm
QCOM
+$4.55M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 13.48%
3 Consumer Discretionary 12.62%
4 Technology 11.4%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DD
2026
DELISTED
Du Pont De Nemours E I
DD
-19,785
Closed -$1.25M
WFM
2027
DELISTED
Whole Foods Market Inc
WFM
-44,756
Closed -$1.39M
NSR
2028
DELISTED
Neustar Inc
NSR
-15,007
Closed -$369K
SFR
2029
DELISTED
Starwood Waypoint Homes
SFR
-27,923
Closed -$691K
TRR
2030
DELISTED
Trc Companies
TRR
-13,509
Closed -$98K
CBR
2031
DELISTED
CIBER Inc.
CBR
-84,847
Closed -$179K
TPLM
2032
DELISTED
Triangle Petroleum Corporation
TPLM
-61,573
Closed -$33K
LLTC
2033
DELISTED
Linear Technology Corp
LLTC
-8,655
Closed -$386K
ACAT
2034
DELISTED
Arctic Cat Inc
ACAT
-25,243
Closed -$424K
ARIA
2035
DELISTED
Ariad Pharmaceuticals Inc
ARIA
-12,099
Closed -$77K
TMH
2036
DELISTED
Team Health Holdings Inc
TMH
-9,919
Closed -$415K
APOL
2037
DELISTED
Apollo Education Group Inc Class A
APOL
-214,362
Closed -$1.76M
IL
2038
DELISTED
IntraLinks Holdings Inc.
IL
-19,568
Closed -$154K
VA
2039
DELISTED
Virgin America Inc.
VA
-9,301
Closed -$359K
MOBI
2040
DELISTED
Sky-mobi Limited ADS
MOBI
-18,176
Closed -$38K
RSTI
2041
DELISTED
Rofin-Sinar Technologies Inc
RSTI
-18,955
Closed -$611K
FCS
2042
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
-25,678
Closed -$514K
NPM
2043
DELISTED
NUVEEN PREMIUM INCM MUNI FD II
NPM
-41,400
Closed -$609K
WPG
2044
DELISTED
Washington Prime Group Inc.
WPG
-2,492
Closed -$213K
QLGC
2045
DELISTED
QLOGIC CORP
QLGC
-33,643
Closed -$452K
MFLX
2046
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
-29,171
Closed -$677K
TE
2047
DELISTED
TECO ENERGY INC
TE
-17,983
Closed -$495K
NTI
2048
DELISTED
NORTHERN TIER ENERGY LP CLASS A
NTI
-69,523
Closed -$1.64M
CVC
2049
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
-7,388
Closed -$244K
AZUR
2050
DELISTED
AZURE MIDSTREAM PARTNERS LP COM UNT LTD PARTNER INT
AZUR
-139,370
Closed -$174K

Similar funds

GSA Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.

  • GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
  • GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
  • GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
  • GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
  • GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
  • GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
  • GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.